Atividade in vitro de antifúngicos em biofilmes de Candida
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFG |
dARK ID: | ark:/38995/0013000002h3s |
Texto Completo: | http://repositorio.bc.ufg.br/tede/handle/tede/9240 |
Resumo: | C. albicans infections may be favored by tissue damages such insertion of medical devices that function as a substrate for fungus growth. This growth can occur in the form of three-dimensional structures formed by yeast and hyphae, coated with a matrix of extracellular polymeric material, forming a biofilm. This agregated of cells is characterized by having greater resistance to host defenses and antifungals, which makes hard treating these infections. This study aimed to determine the kinetics of biofilm formation by isolates of Candida sp. and to evaluate the antifungal susceptibility of plancktonic and sessile cells. We evaluated 10 isolates of C. albicans from different materials, isolated and identified by standardized methods. The minimum inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) of amphotericin B, fluconazole, voriconazole and itraconazole to plancktonic cells were performed according to protocol M27-A3 of Clinical Laboratory Standard Institute (CLSI). Verification of kinetics of biofilms’ formation was assessed at 24 h, 48 h, 72 h and 96 h of incubation at 37 ° C and in vitro susceptibility of sessile cells, was evaluated using the MTT (3 - [4,5-Dimethyl-2-Thiazy] -2,5- Diphenyl-2H-Tetrazolium bromide) assay. The analysis of kinetics at 24 h showed that all isolates produced biofilm and the highest metabolic activity occurred within 48h of growth. Significant differences, on the metabolic activity of biofilms were observed on strains U02, M02 and V60, which produced the highest amount of biofilm with 48 h of growth. MIC values obtained for plancktonic cells ranged from 1 to 8 mg/mL for fluconazole; between 0.0625 to 1 mg/mL for itraconazole; between 0.0312 to 0.25 g/mL for voriconazole; and between 0.25 to 2 mg/mL for amphotericin B. The MFC was twice the MIC for all isolates. For the values obtained for fluconazole the MICS50 ranged from 8 mg/mL to > 1024 mg/mL and MICS80 ≥ 1024 mg/mL. MICS50 for itraconazole ranged from 4 mg/mL to > 16 g/mL and MICS80 ≥ 16 g/mL. The MICS50 for voriconazole showed values between 4 mg/mL and > 16 g/mL and MICS80 ≥ 16 g/mL. Amphotericin B had MICS50 values of 0.25 mg / mL to > 16 g/mL and values MICS80 of 2 mg/mL to > 16 g/mL. We could demonstrate an increased resistance of biofilms to major antifungal drugs by evaluating the susceptibility of C. albicans isolates as plancktonic and sessile cells. These results show the need of new therapeutic or preventive strategies to reduce the mortality rate of patients with infections associated with Candida biofilms. |
id |
UFG-2_9a6fa167d98766759376f0ecc36ecaac |
---|---|
oai_identifier_str |
oai:repositorio.bc.ufg.br:tede/9240 |
network_acronym_str |
UFG-2 |
network_name_str |
Repositório Institucional da UFG |
repository_id_str |
|
spelling |
Souza, Lúcia Kioko Hasimoto ehttp://lattes.cnpq.br/4557218510118165Souza, Lúcia Kioko Hasimoto eFaganello, JosianeSilva, Maria do Rosário Rodrigueshttp://lattes.cnpq.br/8992795603947194Pereira, Núbia Pontes2019-01-22T10:53:29Z2011-05-16PEREIRA, Núbia Pontes. Atividade in vitro de antifúngicos em biofilmes de Candida. 2011. 67 f. Dissertação (Mestrado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2011.http://repositorio.bc.ufg.br/tede/handle/tede/9240ark:/38995/0013000002h3sC. albicans infections may be favored by tissue damages such insertion of medical devices that function as a substrate for fungus growth. This growth can occur in the form of three-dimensional structures formed by yeast and hyphae, coated with a matrix of extracellular polymeric material, forming a biofilm. This agregated of cells is characterized by having greater resistance to host defenses and antifungals, which makes hard treating these infections. This study aimed to determine the kinetics of biofilm formation by isolates of Candida sp. and to evaluate the antifungal susceptibility of plancktonic and sessile cells. We evaluated 10 isolates of C. albicans from different materials, isolated and identified by standardized methods. The minimum inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) of amphotericin B, fluconazole, voriconazole and itraconazole to plancktonic cells were performed according to protocol M27-A3 of Clinical Laboratory Standard Institute (CLSI). Verification of kinetics of biofilms’ formation was assessed at 24 h, 48 h, 72 h and 96 h of incubation at 37 ° C and in vitro susceptibility of sessile cells, was evaluated using the MTT (3 - [4,5-Dimethyl-2-Thiazy] -2,5- Diphenyl-2H-Tetrazolium bromide) assay. The analysis of kinetics at 24 h showed that all isolates produced biofilm and the highest metabolic activity occurred within 48h of growth. Significant differences, on the metabolic activity of biofilms were observed on strains U02, M02 and V60, which produced the highest amount of biofilm with 48 h of growth. MIC values obtained for plancktonic cells ranged from 1 to 8 mg/mL for fluconazole; between 0.0625 to 1 mg/mL for itraconazole; between 0.0312 to 0.25 g/mL for voriconazole; and between 0.25 to 2 mg/mL for amphotericin B. The MFC was twice the MIC for all isolates. For the values obtained for fluconazole the MICS50 ranged from 8 mg/mL to > 1024 mg/mL and MICS80 ≥ 1024 mg/mL. MICS50 for itraconazole ranged from 4 mg/mL to > 16 g/mL and MICS80 ≥ 16 g/mL. The MICS50 for voriconazole showed values between 4 mg/mL and > 16 g/mL and MICS80 ≥ 16 g/mL. Amphotericin B had MICS50 values of 0.25 mg / mL to > 16 g/mL and values MICS80 of 2 mg/mL to > 16 g/mL. We could demonstrate an increased resistance of biofilms to major antifungal drugs by evaluating the susceptibility of C. albicans isolates as plancktonic and sessile cells. These results show the need of new therapeutic or preventive strategies to reduce the mortality rate of patients with infections associated with Candida biofilms.Infecções por C. albicans podem ser favorecidas por danos causados aos tecidos, como na inserção de dispositivos médicos, que funcionam como substrato para o crescimento do fungo. Este crescimento pode ocorrer na forma de estruturas tridimensionais, formadas por leveduras e hifas, revestidas por uma matriz de material polimérico extracelular, configurando um biofilme. Este agregado de células caracteriza-se por apresentar maior resistência às defesas do hospedeiro e aos antifúngicos, dificultando o tratamento destas infecções. Este trabalho teve como objetivo verificar a cinética de formação de biofilmes por isolados de Candida, e avaliar a suscetibilidade antifúngica de suas células planquitônicas e sésseis. Foram avaliados 10 isolados de C. albicans, provenientes de diferentes materiais, isolados e identificados por métodos padronizados. As concentrações inibitórias mínimas (CIMs) e concentração fungicida mínima (CFM) para anfotericina B, fluconazol, voriconazol e itraconazol de células planquitônicas foram realizadas segundo o protocolo M27-A3 do Clinical Laboratory Standard Institute (CLSI). A verificação da cinética de formação dos biofilmes foi avaliada em 24 h, 48 h, 72 h e 96 h de incubação a 37oC e a suscetibilidade in vitro das células sésseis, foi avaliada utilizando-se o ensaio de MTT (3-[4,5-Dimethyl-2-Thiazyl]-2,5-Diphenyl-2H-Tetrazolium bromide). A análise da cinética de formação mostrou que com 24 h todos os isolados formaram biofilme e, a maior atividade metabólica ocorreu com 48h de crescimento. Diferenças significativas, quanto à atividade metabólica dos biofilmes, foram observadas, sendo os isolados U02, M02 e V60 os que produziram mais biofilme com 48 h de crescimento. Os valores de CIM das células plaquitônicas (CIMP) obtidos para fluconazol variaram de 1 a 8 μg/mL; para itraconazol entre 0,0625 a 1 μg/mL; para voriconazol entre 0,0312 a 0,25 μg/mL e para anfotericina B de 0,25 a 2 μg/mL. A CFM apresentada por todos os isolados avaliados foi o dobro do obtido para a CIM. Para fluconazol os valores de concentração inibitória mínima que reduzirma em 50% a atividade metabólica das células sésseis (CIMS50), variaram de 8 μg/mL a > 1.024 μg/mL e foi ≥ 1.024 μg/mL quando observada uma inibição de 80% da atividade metabólica destas células (CIMS80). Com itraconazol a CIMS50 variou de 4 μg/mL a > 16 μg/mL e a CIMS80 ≥16 μg/mL. A CIMS50 de voriconazol mostrou valores de 4 μg/mL a > 16 μg/mL e a CIMS80 ≥16 μg/mL. Anfotericina B apresentou valores de CIMS50 de 0,25 μg/mL a > 16 μg/mL e valores de CIMS80 de 2 μg/mL a > 16 μg/mL. Através da avaliação da suscetibilidade de isolados de C. albicans, sob a forma de células planquitônicas e biofilmes, foi possível demonstrar um aumento da resistência dos isolados aos principais antifúngicos, tornando necessárias novas estratégias terapêuticas ou preventivas a fim de diminuir a taxa de mortalidade de pacientes com infecções associadas aos biofilmes de Candida.Submitted by Ana Caroline Costa (ana_caroline212@hotmail.com) on 2019-01-21T17:59:55Z No. of bitstreams: 2 Dissertação - Núbia Pontes Pereira - 2011.pdf: 2541686 bytes, checksum: 78b3a93f16f2f902fdbea39491f62fe2 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2019-01-22T10:53:29Z (GMT) No. of bitstreams: 2 Dissertação - Núbia Pontes Pereira - 2011.pdf: 2541686 bytes, checksum: 78b3a93f16f2f902fdbea39491f62fe2 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5)Made available in DSpace on 2019-01-22T10:53:29Z (GMT). No. of bitstreams: 2 Dissertação - Núbia Pontes Pereira - 2011.pdf: 2541686 bytes, checksum: 78b3a93f16f2f902fdbea39491f62fe2 (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2011-05-16application/pdfporUniversidade Federal de GoiásPrograma de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP)UFGBrasilInstituto de Patologia Tropical e Saúde Pública - IPTSP (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessCandidaBiofilmeSuscetibilidadeAntifúngicosInfecçõesBiofilmSusceptibilityAntifungalsInfectionsBIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS::MICOLOGIAAtividade in vitro de antifúngicos em biofilmes de CandidaIn vitro activity of antifungals in Candida biofilmsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis6085308344741430434600600600-77690114445645562881258845414555579790reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/43df0a3b-e73d-4ef0-945e-542a2fa84f0b/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/a2a8cca7-4ca6-4ffa-bb74-2f454b17db0b/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/9e8ef032-5305-4b7a-9ab5-f2214da0213c/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/ca58bdb4-3c96-4f08-bdf2-cea97f87c325/downloadd41d8cd98f00b204e9800998ecf8427eMD54ORIGINALDissertação - Núbia Pontes Pereira - 2011.pdfDissertação - Núbia Pontes Pereira - 2011.pdfapplication/pdf2541686http://repositorio.bc.ufg.br/tede/bitstreams/9d380229-7405-40fb-b22b-91bfa1437b97/download78b3a93f16f2f902fdbea39491f62fe2MD55tede/92402019-01-22 08:53:29.742http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/9240http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2019-01-22T10:53:29Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
dc.title.eng.fl_str_mv |
Atividade in vitro de antifúngicos em biofilmes de Candida |
dc.title.alternative.eng.fl_str_mv |
In vitro activity of antifungals in Candida biofilms |
title |
Atividade in vitro de antifúngicos em biofilmes de Candida |
spellingShingle |
Atividade in vitro de antifúngicos em biofilmes de Candida Pereira, Núbia Pontes Candida Biofilme Suscetibilidade Antifúngicos Infecções Biofilm Susceptibility Antifungals Infections BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS::MICOLOGIA |
title_short |
Atividade in vitro de antifúngicos em biofilmes de Candida |
title_full |
Atividade in vitro de antifúngicos em biofilmes de Candida |
title_fullStr |
Atividade in vitro de antifúngicos em biofilmes de Candida |
title_full_unstemmed |
Atividade in vitro de antifúngicos em biofilmes de Candida |
title_sort |
Atividade in vitro de antifúngicos em biofilmes de Candida |
author |
Pereira, Núbia Pontes |
author_facet |
Pereira, Núbia Pontes |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Souza, Lúcia Kioko Hasimoto e |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/4557218510118165 |
dc.contributor.referee1.fl_str_mv |
Souza, Lúcia Kioko Hasimoto e |
dc.contributor.referee2.fl_str_mv |
Faganello, Josiane |
dc.contributor.referee3.fl_str_mv |
Silva, Maria do Rosário Rodrigues |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/8992795603947194 |
dc.contributor.author.fl_str_mv |
Pereira, Núbia Pontes |
contributor_str_mv |
Souza, Lúcia Kioko Hasimoto e Souza, Lúcia Kioko Hasimoto e Faganello, Josiane Silva, Maria do Rosário Rodrigues |
dc.subject.por.fl_str_mv |
Candida Biofilme Suscetibilidade Antifúngicos Infecções |
topic |
Candida Biofilme Suscetibilidade Antifúngicos Infecções Biofilm Susceptibility Antifungals Infections BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS::MICOLOGIA |
dc.subject.eng.fl_str_mv |
Biofilm Susceptibility Antifungals Infections |
dc.subject.cnpq.fl_str_mv |
BIOLOGIA E FISIOLOGIA DOS MICROORGANISMOS::MICOLOGIA |
description |
C. albicans infections may be favored by tissue damages such insertion of medical devices that function as a substrate for fungus growth. This growth can occur in the form of three-dimensional structures formed by yeast and hyphae, coated with a matrix of extracellular polymeric material, forming a biofilm. This agregated of cells is characterized by having greater resistance to host defenses and antifungals, which makes hard treating these infections. This study aimed to determine the kinetics of biofilm formation by isolates of Candida sp. and to evaluate the antifungal susceptibility of plancktonic and sessile cells. We evaluated 10 isolates of C. albicans from different materials, isolated and identified by standardized methods. The minimum inhibitory concentrations (MICs) and minimal fungicidal concentrations (MFCs) of amphotericin B, fluconazole, voriconazole and itraconazole to plancktonic cells were performed according to protocol M27-A3 of Clinical Laboratory Standard Institute (CLSI). Verification of kinetics of biofilms’ formation was assessed at 24 h, 48 h, 72 h and 96 h of incubation at 37 ° C and in vitro susceptibility of sessile cells, was evaluated using the MTT (3 - [4,5-Dimethyl-2-Thiazy] -2,5- Diphenyl-2H-Tetrazolium bromide) assay. The analysis of kinetics at 24 h showed that all isolates produced biofilm and the highest metabolic activity occurred within 48h of growth. Significant differences, on the metabolic activity of biofilms were observed on strains U02, M02 and V60, which produced the highest amount of biofilm with 48 h of growth. MIC values obtained for plancktonic cells ranged from 1 to 8 mg/mL for fluconazole; between 0.0625 to 1 mg/mL for itraconazole; between 0.0312 to 0.25 g/mL for voriconazole; and between 0.25 to 2 mg/mL for amphotericin B. The MFC was twice the MIC for all isolates. For the values obtained for fluconazole the MICS50 ranged from 8 mg/mL to > 1024 mg/mL and MICS80 ≥ 1024 mg/mL. MICS50 for itraconazole ranged from 4 mg/mL to > 16 g/mL and MICS80 ≥ 16 g/mL. The MICS50 for voriconazole showed values between 4 mg/mL and > 16 g/mL and MICS80 ≥ 16 g/mL. Amphotericin B had MICS50 values of 0.25 mg / mL to > 16 g/mL and values MICS80 of 2 mg/mL to > 16 g/mL. We could demonstrate an increased resistance of biofilms to major antifungal drugs by evaluating the susceptibility of C. albicans isolates as plancktonic and sessile cells. These results show the need of new therapeutic or preventive strategies to reduce the mortality rate of patients with infections associated with Candida biofilms. |
publishDate |
2011 |
dc.date.issued.fl_str_mv |
2011-05-16 |
dc.date.accessioned.fl_str_mv |
2019-01-22T10:53:29Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
PEREIRA, Núbia Pontes. Atividade in vitro de antifúngicos em biofilmes de Candida. 2011. 67 f. Dissertação (Mestrado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2011. |
dc.identifier.uri.fl_str_mv |
http://repositorio.bc.ufg.br/tede/handle/tede/9240 |
dc.identifier.dark.fl_str_mv |
ark:/38995/0013000002h3s |
identifier_str_mv |
PEREIRA, Núbia Pontes. Atividade in vitro de antifúngicos em biofilmes de Candida. 2011. 67 f. Dissertação (Mestrado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2011. ark:/38995/0013000002h3s |
url |
http://repositorio.bc.ufg.br/tede/handle/tede/9240 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.program.fl_str_mv |
6085308344741430434 |
dc.relation.confidence.fl_str_mv |
600 600 600 |
dc.relation.department.fl_str_mv |
-7769011444564556288 |
dc.relation.cnpq.fl_str_mv |
1258845414555579790 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.publisher.program.fl_str_mv |
Programa de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP) |
dc.publisher.initials.fl_str_mv |
UFG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Instituto de Patologia Tropical e Saúde Pública - IPTSP (RG) |
publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
instname_str |
Universidade Federal de Goiás (UFG) |
instacron_str |
UFG |
institution |
UFG |
reponame_str |
Repositório Institucional da UFG |
collection |
Repositório Institucional da UFG |
bitstream.url.fl_str_mv |
http://repositorio.bc.ufg.br/tede/bitstreams/43df0a3b-e73d-4ef0-945e-542a2fa84f0b/download http://repositorio.bc.ufg.br/tede/bitstreams/a2a8cca7-4ca6-4ffa-bb74-2f454b17db0b/download http://repositorio.bc.ufg.br/tede/bitstreams/9e8ef032-5305-4b7a-9ab5-f2214da0213c/download http://repositorio.bc.ufg.br/tede/bitstreams/ca58bdb4-3c96-4f08-bdf2-cea97f87c325/download http://repositorio.bc.ufg.br/tede/bitstreams/9d380229-7405-40fb-b22b-91bfa1437b97/download |
bitstream.checksum.fl_str_mv |
bd3efa91386c1718a7f26a329fdcb468 4afdbb8c545fd630ea7db775da747b2f d41d8cd98f00b204e9800998ecf8427e d41d8cd98f00b204e9800998ecf8427e 78b3a93f16f2f902fdbea39491f62fe2 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
repository.mail.fl_str_mv |
tasesdissertacoes.bc@ufg.br |
_version_ |
1813816873078226944 |